The Delta>15 Kb deletion French Canadian founder mutation in familial hypercholesterolemia: rapid polymerase chain reaction-based diagnostic assay and prevalence in Quebec
- PMID: 14756670
- DOI: 10.1111/j.0009-9163.2004.00223.x
The Delta>15 Kb deletion French Canadian founder mutation in familial hypercholesterolemia: rapid polymerase chain reaction-based diagnostic assay and prevalence in Quebec
Abstract
Approximately one in 500 individuals in Western population has autosomal dominant familial hypercholesterolemia due to mutations in the low-density lipoprotein receptor (LDLR) gene. Screening for these mutations is hampered by their large number, except in founder populations. We identified the breakpoint of the >15 kb deletion involving the LDLR gene promoter and exon 1, responsible for more than 60% of French Canadian hypercholesterolemia cases, as well as the breakpoint of the 5 kb deletion of exons 2 and 3 that accounts for an additional 5% of cases. Both deletions appear to be because of homologous recombination by unequal crossing-over between the left arms of Alu repeats. Using RepeatMasker, we determined that 55% of the LDLR gene is composed of Alu elements; thus, it is not surprising that most LDLR rearrangements involve at least one Alu. Furthermore, we developed a rapid polymerase chain reaction-based assay for the French Canadian-1 (>15 kb) and French Canadian-5 (5 kb) hypercholesterolemia alleles. Screening a representative population sample of 943 French Canadian youths whose LDL cholesterol levels were above the 50th percentile allowed us to estimate the prevalence of the >15 kb allele as 0.11% (95% confidence interval, 0.03-0.38).
Similar articles
-
Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations.Atherosclerosis. 1999 Mar;143(1):145-51. doi: 10.1016/s0021-9150(98)00267-6. Atherosclerosis. 1999. PMID: 10208489
-
Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.Hum Mutat. 2001 Oct;18(4):359. doi: 10.1002/humu.1205. Hum Mutat. 2001. PMID: 11668627
-
Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec.Clin Genet. 1997 Jul;52(1):1-6. doi: 10.1111/j.1399-0004.1997.tb02506.x. Clin Genet. 1997. PMID: 9272705
-
Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".Am J Cardiol. 1993 Sep 30;72(10):6D-10D. doi: 10.1016/0002-9149(93)90003-u. Am J Cardiol. 1993. PMID: 8213499 Review.
-
[Molecular biology in the diagnosis and phenotypic expression of familial hypercholesterolemia in French Canadians].Union Med Can. 1995 Sep;124(2):48-53. Union Med Can. 1995. PMID: 8846257 Review. French. No abstract available.
Cited by
-
Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.Am J Hum Genet. 2008 Feb;82(2):320-32. doi: 10.1016/j.ajhg.2007.10.011. Am J Hum Genet. 2008. PMID: 18252213 Free PMC article.
-
Decreased dystrophin expression and elevated dystrophin-targeting miRNAs in anti-HMGCR immune-mediated necrotizing myopathy.Acta Neuropathol. 2023 Oct;146(4):655-658. doi: 10.1007/s00401-023-02619-4. Epub 2023 Aug 5. Acta Neuropathol. 2023. PMID: 37543531 No abstract available.
-
Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis.Mol Genet Genomic Med. 2019 Dec;7(12):e1007. doi: 10.1002/mgg3.1007. Epub 2019 Oct 16. Mol Genet Genomic Med. 2019. PMID: 31617323 Free PMC article.
-
Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.Circ Genom Precis Med. 2019 Jun;12(6):e002481. doi: 10.1161/CIRCGEN.119.002481. Epub 2019 Jun 11. Circ Genom Precis Med. 2019. PMID: 31184202 Free PMC article.
-
Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen.Front Med (Lausanne). 2021 Jun 25;8:694668. doi: 10.3389/fmed.2021.694668. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34249980 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical